Kangen Pharmaceuticals Co Ltd
http://kangenpharma.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Kangen Pharmaceuticals Co Ltd
CalciMedica Eyes Success In Pancreatitis, Acute Kidney Injury
Phase IIb data for Auxora in an acute pancreatitis subpopulation is expected to set up the CRAC channel inhibitor for Phase III in that indication while suggesting positive read-through for AKI.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Stason Pharma Japan
- KC Specialty therapeutics, LLC
- Kangen Pharmaceuticals America LLC
- Kangen Pharmaceuticals, Inc
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice